Macroaxis provides advice on Balchem Cp to complement and cross-verify current
analyst consensus on Balchem Cp. Our investment recommendation engine determines the company's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. This firm dividends can provide a clue to the current value of the stock. Balchem Cp one year expected dividend income is about $0.17 per share.
Typically, a company's
financial statements are the reports that show the
financial position of the company. There are three main documents that fall into the category of financial statements. These documents include Balchem income statement, its balance sheet, and the statement of cash flows. Potential Balchem investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Balchem investors may use each financial statement separately, they are all related. The changes in Balchem's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Balchem's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our
technical analysis and
fundamental analysis pages.
The goal of Balchem
fundamental analysis is to do accurate financial forecasts. There are several possible objectives to fundamental analysis, such as projecting of Balchem performance into the future periods or doing a reasonable stock valuation. The intrinsic value of Balchem shares is the value that is considered the true value of the share. If
the intrinsic value of Balchem is higher than its market price, buying is generally recommended. If it is equal to the market price, it is recommended to hold; and if it is less than the market price, then one should sell all shares Balchem. Please read more on our
fundamental analysis page.
How effective is Balchem in utilizing its assets?
Balchem reports assets on its Balance Sheet. It represents the amount of Balchem resources that either has an existing economic value or will provide some form of benefits in the future. By effectively utilizing its assets, Balchem aims to generate revenue, control costs, drive operational efficiency, and enhance profitability. Optimizing asset utilization helps maximize shareholder value and maintain a competitive position in the Specialty Chemicals space. To get a better handle on how balance sheet or income statements item affect Balchem volatility, please check the breakdown of all its
fundamentals.
Are Balchem Earnings Expected to grow?
The
future earnings power of Balchem involves the interaction of many company-specific, industry, and economic forces. Earnings estimates embody investors' opinions of Balchem factors such as sales growth, product demand, competitive industry environment, profit margins, and cost controls. Balchem
stock prices adjust as these expectations change or are proven wrong. The main thing to remember is that equities with high expected earnings growth tend to underperform the market because it is usually difficult to meet the market's high expectations. Companies with low earnings expectations tend to do better than expected. Please use our latest analysis of Balchem
expected earnings.
And What about dividends?
A dividend is the distribution of a portion of Balchem earnings, decided and managed by the company's board of directors and paid to a class of its shareholders. Note, announcements of dividend payouts are generally accompanied by a proportional increase or decrease in a company's stock price. Balchem dividend payments follow a chronological order of events, and the associated dates are important to determine the shareholders who qualify for receiving the dividend payment. Balchem one year expected dividend income is about USD0.63 per share.
The current year's
Dividend Payout Ratio is expected to grow to 0.22, whereas
Dividends Paid is projected to grow to (21.7
M).
Investing in stocks that pay
dividends, such as stock of Balchem, is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Balchem must own a stock before its ex-dividend date to receive its next dividend.
This type of analysis is very useful when you want to generate a past dividend schedule and payout information for Balchem. Then that information in the form of graph and calendar can be used to fully explain how Du Pont dividends can provide a real clue to its valuation.
Balchem Gross Profit
Balchem Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Balchem previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Balchem Gross Profit growth over the last 10 years. Please check Balchem's
gross profit and other
fundamental indicators for more details.
Going after Balchem Financials
There are few distinct groups of Balchem Cp stakehholders that the SEC considers insiders. Investors usually gain information through their work as corporate directors, officers, or employees. If these individuals share the information with a friend, family, or business partner and the person who receives the information exchanges stock in the company, he or shie is also an insider. Let's take a look at how the ownership of Balchem is distributed among investors.
Ownership Allocation
Balchem Cp retains a total of 32.35 Million outstanding shares. The majority of Balchem Cp
outstanding shares are owned by
other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Balchem Cp to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Balchem Cp. Please pay attention to any change in the institutional holdings of Balchem Cp as this could imply that something significant has changed or about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
| Retail Investors11.92% | | Institutions87.33% |
| Retail Investors | 11.92 |
| Insiders | 0.75 |
| Institutions | 87.33 |
| 2018 | 2019 | 2020 | 2021 (projected) |
Consolidated Income | 78.57 M | 79.67 M | 91.62 M | 81.44 M | Direct Expenses | 439.43 M | 432.34 M | 389.1 M | 342.69 M |
Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Balchem Cp has an asset utilization ratio of 78.24 percent. This suggests that the company is making $0.78 for each dollar of assets. An increasing asset utilization means that Balchem Cp is more efficient with each dollar of assets it utilizes for everyday operations.
| Assets Non Current831 M | Goodwill615.2 M | |
| Current Assets | 272.63 Million | 15.8 |
| Assets Non Current | 830.98 Million | 48.17 |
| Goodwill | 615.15 Million | 35.66 |
| Tax Assets | 6.33 Million | 0.37 |
Balchem Cp is projected to stay under $117 in March
Current Information Ratio is up to 0.01. Price may slip again. Balchem Cp has relatively low volatility with skewness of 0.61 and kurtosis of 4.02. However, we advise all investors to independently investigate Balchem Cp to ensure all accessible information is consistent with the expectations about its upside potential and future expected returns.
Whereas other entities under the specialty chemicals industry are still a bit expensive, Balchem Cp may offer a potential longer-term growth to investors. On the whole, as of the 19th of February 2021, we see that Balchem Cp responds to the market. The company is
fairly valued with
very low probability of distress within the next 24 months. Our concluding 30 days recommendation on the company is
Strong Hold.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Vlad Skutelnik is a Macroaxis Contributor. Vlad covers stocks, funds, cryptocurrencies, and ETFs that are traded in North America, focusing primarily on fundamentals, valuation and market volatility. He has many years of experience in fintech, predictive investment analytics, and risk management.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of Balchem. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com